{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:04:37Z","timestamp":1759773877685,"version":"3.37.3"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1005482","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T13:34:35Z","timestamp":1499348075000},"page":"e1005482","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8213-1797","authenticated-orcid":true,"given":"Kamran","family":"Kaveh","sequence":"first","affiliation":[]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5569-0366","authenticated-orcid":true,"given":"Michael A.","family":"Farrar","sequence":"additional","affiliation":[]},{"given":"Guy","family":"Storme","sequence":"additional","affiliation":[]},{"given":"Marcucci","family":"Guido","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8067-8510","authenticated-orcid":true,"given":"Jamie","family":"Piepenburg","sequence":"additional","affiliation":[]},{"given":"Jackson","family":"Penning","sequence":"additional","affiliation":[]},{"given":"Jasmine","family":"Foo","sequence":"additional","affiliation":[]},{"given":"Kevin Z.","family":"Leder","sequence":"additional","affiliation":[]},{"given":"Susanta K.","family":"Hui","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"M Deininger","year":"2005","journal-title":"Blood"},{"issue":"24","key":"ref2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome\u2013positive leukemias","volume":"354","author":"M Talpaz","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cncr.29141","article-title":"Phase 1\/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome\u2013positive acute lymphoblastic leukemia","volume":"121","author":"A Shimoni","year":"2015","journal-title":"Cancer"},{"issue":"24","key":"ref4","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome\u2013positive ALL","volume":"354","author":"H Kantarjian","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2141.2005.05773.x","article-title":"Childhood acute lymphoblastic leukaemia and relapse","volume":"131","author":"PS Gaynon","year":"2005","journal-title":"British journal of haematology"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"CH Pui","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"ML Den Boer","year":"2009","journal-title":"The lancet oncology"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.critrevonc.2014.11.001","article-title":"Mechanisms of resistance to BCR\u2013ABL TKIs and the therapeutic strategies: A review","volume":"93","author":"K Yang","year":"2015","journal-title":"Critical reviews in oncology\/hematology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/leusup.2012.7","article-title":"Management of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"1","author":"O Ottmann","year":"2012","journal-title":"Leukemia supplements"},{"issue":"1","key":"ref10","first-page":"371","article-title":"Management of Philadelphia chromosome\u2013positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"2009","author":"OG Ottmann","year":"2009","journal-title":"ASH Education Program Book"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4161\/onci.20249","article-title":"Environment-mediated drug resistance in Bcr\/Abl-positive acute lymphoblastic leukemia","volume":"1","author":"N Feldhahn","year":"2012","journal-title":"Oncoimmunology"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s12185-016-2063-6","article-title":"Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia","volume":"104","author":"JH Kwon","year":"2016","journal-title":"International journal of hematology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2012.03.033","article-title":"Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"85","author":"JY Wong","year":"2013","journal-title":"International Journal of Radiation Oncology* Biology* Physics"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19 ARF","volume":"91","author":"T Kamijo","year":"1997","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-8301-4","article-title":"Targeted cancer treatment in silico","author":"NL Komarova","year":"2014"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0025-5564(97)00080-1","article-title":"A mathematical model of drug resistance: heterogeneous tumors","volume":"147","author":"JC Panetta","year":"1998","journal-title":"Mathematical biosciences"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1088\/0031-9155\/18\/1\/007","article-title":"A molecular theory of cell survival","volume":"18","author":"K Chadwick","year":"1973","journal-title":"Physics in medicine and biology"},{"article-title":"Radiobiological modelling in radiation oncology","year":"2007","author":"RG Dale","key":"ref18"},{"article-title":"Radiobiology for the Radiologist","year":"2006","author":"EJ Hall","key":"ref19"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0360-3016(95)00544-9","article-title":"A convenient extension of the linear-quadratic model to include redistribution and reoxygenation","volume":"32","author":"DJ Brenner","year":"1995","journal-title":"International Journal of Radiation Oncology* Biology* Physics"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1118\/1.2044428","article-title":"Feasibility study of helical tomotherapy for total body or total marrow irradiationan","volume":"32","author":"SK Hui","year":"2005","journal-title":"Medical physics"},{"key":"ref22","article-title":"Evaluation of functional marrow irradiation based on skeletal marrow composition obtained using dual-energy CT","author":"T Magome","year":"2016","journal-title":"international Journal of Radiation Oncology"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2010-06-288357","article-title":"Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies","volume":"117","author":"J Rosenthal","year":"2011","journal-title":"Blood"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T15:17:19Z","timestamp":1539962239000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005482"}},"subtitle":[],"editor":[{"given":"Benjamin","family":"Werner","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1005482","relation":{},"ISSN":["1553-7358"],"issn-type":[{"type":"electronic","value":"1553-7358"}],"subject":[],"published":{"date-parts":[[2017,7,6]]}}}